The medical devices sector is typified by frequent change and innovation, in response to problems and issues faced by the healthcare industry. As a result, the sector has seen the emergence of several start-up medtech companies offering disruptive, cutting-edge solutions. Most of these are private companies, where data such as revenue is frequently not disclosed. National estimates for Qvella sales in the US from 2016 to 2022, as well as year-on-year growth rates, can be viewed in GlobalData’s micro revenue report. Buy the report here.

Smarter leaders trust GlobalData


Data Insights Qvella Corp, United States Revenue

Buy the Report

Data Insights

The gold standard of business intelligence.

Find out more

Qvella Corp (Qvella) is a molecular diagnostics company that develops differentiated technology for rapid detection of pathogens causing Sepsis by direct sampling of bodily fluids. Its Field Activated Sample Treatment (FAST) -ID technology utilizes a novel electrical lysing and sample treatment technique that enables the rapid detection of infectious pathogens from direct blood samples without the need of sample processing. In addition, Qvella’s FAST-ID BSI cartridge is designed for isolation, lysis, amplification, and detection of rRNA from intact pathogens to improve the triage and management of patients with bacteria. Qvella is headquartered in Richmond Hill, Ontario, Canada. Key subsidiaries of Qvella include NOVX Systems.

The key metrics of Qvella related to marketed and pipeline products, ongoing clinical trials, active jobs and publications from 2022 are shown below:

As Qvella is a privately held company, it is not required to disclose its financial information and there is no stock listed on an exchange. GlobalData has access to a proprietary data set containing invoice data from over 2,600 healthcare institutions in the US and is therefore able to use estimations of a company’s revenue and growth to value private companies such as Qvella.

For a detailed understanding of the performance of Qvella, buy the report here.

Data Insights


The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.


GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article. 

GlobalData’s revenue report leverages GlobalData’s SKU tracker, which contains real-world, purchasing data from the US healthcare institutions.